Loading stock data…
P3 Health Partners Inc. (PIII)
$11.94+0.63 (+5.57%)
Market ClosedLast close Jun 29
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
P3 Health Partners Inc. in the Healthcare sector is trading at $11.94 with a market capitalization of $2.5B. Wall Street consensus targets $14.00 (2 analysts), implying a +17.3% move over the next 12 months. The stock is currently 29% below its 52-week high of $16.89, remaining 104.1% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +17.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $386.39M↑ | $384.81M↑ | $345.25M↓ | $355.79M↓ | $373.23M |
| Gross Profit | — | — | — | — | — |
| Operating Income | $8.24M↑ | -$153.87M↓ | -$44.22M↓ | -$34.12M↑ | -$38.09M |
| Net Income | $1.22M↑ | -$75.52M↓ | -$31.59M↓ | -$20.36M↑ | -$20.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Hender...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.55B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.60
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
87.12%
Volume
Today's trading volume
33,007
Recent News
P3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And Guidance
The latest update for P3 Health Partners lifts the internal fair value reference from $10.25 to $14.00, signaling a higher price target in current analyst models. That move is tied closely to recent commentary that balances optimism about 2026 execution, cleaner debt and equity structures, and higher EBITDA guidance with caution around how durable the reset in sentiment and valuation may be. As you read on, you will see how this evolving narrative might shape the way you track P3 Health...
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion. ... Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
Top Midday Gainers
P3 Health Partners' (PIII) shares soared 182% amid heavy trading after the company posted overnight
P3 Health Partners Inc. Q1 2026 Earnings Call Summary
Moby summary of P3 Health Partners Inc.'s Q1 2026 earnings call
P3 Health Partners Inc (PIII) Q1 2026 Earnings Call Highlights: Surpassing Expectations and ...
P3 Health Partners Inc (PIII) reports robust Q1 performance, raises full-year outlook, and enhances balance sheet through strategic debt conversion.